Login
From:
MedicalResearch.com | Top Innovations in 2025 That Help Patients and Professi...
(Uncensored)
subscribe
EASD 2025: Tirzepatide (Zepbound) Improved Weight Loss and Glucose Levels in Type I Diabetes
https://medicalresearch.com/easd-2025-tirzepatide-zepbound-improved-weight-loss-and-glucose-levels-in-type-i-diabetes/
links
backlinks
Tagged with:
diabetes
zepbound
sheffielduni
easdnews
Roast topics
Find topics
Find it!
One group that requires particular attention is young adults with type 1 diabetes, who might benefit further from the cardiovascular and metabolic benefits of tirzepatide cumulatively over a longer time period.
